ReviewFuture oncology (London, England)2022

A phase Ib feasibility trial of response adapted neoadjuvant therapy in gastric cancer (RANT-GC).

Farshid Dayyani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.